Clinical trial
FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
NCT06539169 is registered in ClinicalTrials.gov with xCures as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases
- Lead sponsor
- xCures
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- June 10, 2024
- Completion date
- June 10, 2026
- Enrollment
- 1,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
alpha-thalassemia, amyloidosis, amyotrophic lateral sclerosis, beta-thalassemia, creutzfeld-jakob disease, cystic fibrosis, duchenne muscular dystrophy, early-onset alzheimer disease, ehlers-danlos syndrome, gaucher disease, gm1 gangliosidosis, huntington disease, myasthenia gravis, pompe disease, rare diseases, sickle cell disease, transthyretin amyloid cardiomyopathy